#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hydrocephalus Systemic sclerosis pulmonary Uterine leiomyosarcoma Medullary thyroid cancer Dilated cardiomyopathy Thalassaemia alpha Primary biliary cholangitis Cervix carcinoma Crohn's disease Neuroendocrine tumour of the lung Chondrosarcoma metastatic Undifferentiated sarcoma Primary amyloidosis Neurodegenerative disorder Candida infection More trials…

    Learn about Rare Diseases

    Richter’s syndrome – Basic Information Mucopolysaccharidosis III – Basic Information Mantle cell lymphoma stage II – Trials in Disease Castleman’s disease – Trials in Disease Mantle cell lymphoma refractory – Treatment Uterine leiomyosarcoma – Basic Information SAPHO syndrome – Diagnostics Osteosarcoma metastatic – Diagnostics Brain stem glioma – Trials in Disease KBG syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Daunorubicin Ferumoxytol Vamorolone [18F]Fapi-74 Oritavancin POLYSORBATE 80 Eribulin Mesylate Milrinone Mk-1167 NALMEFENE HYDROCHLORIDE Ads-011 Efruxifermin Balstilimab Rintatolimod Elenestinib Phosphate CYCLIZINE HYDROCHLORIDE Art0380 Mesilate Sqy51 INSULIN DEGLUDEC Nalbuphine Hydrochloride More therapies…

    Learn about Your Condition

    Asthma Endometrial cancer stage II Rectal cancer stage III Metastatic malignant melanoma Pain in extremity Hyperlipidaemia Adenomatous polyposis coli Pyelonephritis acute Epicondylitis Dilated cardiomyopathy Somatic symptom disorder Obstructive airways disorder Cushing's syndrome Non-obstructive cardiomyopathy Peritoneal dialysis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Falu lasarett

Falu lasarett

Falu lasarett Reumatologi, Falun, 79182, Sweden

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Apixaban and Warfarin for Patients with Heart Clots After a Heart Attack

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac ventricular thrombosis
    • Acute myocardial infarction
    Investigated Drugs:
    • Sulfur Hexafluoride
    • Perflutren
    • Apixaban
    Denmark Sweden

  • Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Abatacept
    • Certolizumab Pegol
    • Hydroxychloroquine Sulfate
    Denmark Iceland Norway Sweden

  • Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Elranatamab
    • Daratumumab
    • Dexamethasone
    Austria Belgium Czechia Finland France Germany +7

  • Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Evolocumab
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!